8-K current report · filed Oct 14, 2026

Beauty Health Co (SKIN) 8-K Current Report: October 14, 2026

Item 5.03Item EX-99.1Item 3.03Item 7.01SKIN overview

Short answer

Beauty Health Co (SKIN) filed an 8-K current report with the SEC on October 14, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item EX-99.1 (Exhibit EX-99.1), Item 3.03 (Material Modification to Rights of Security Holders), Item 7.01 (Regulation FD Disclosure). Item 3.03 points investors to the reverse stock split disclosure under Item 5.03.

Beauty Health Co 8-K event analysis

AI summary of each reported item and its exhibits

Item 3.03 · Material Modification to Rights of Security Holders

  • Item 3.03 points investors to the reverse stock split disclosure under Item 5.03
  • Reverse stock split represents a material change to shareholders’ ownership structure and per-share economics
  • Shareholders should review Item 5.03 for the split ratio, effective date, and treatment of fractional shares

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

  • 1-for-20 reverse split effective October 14, 2026, reducing shares outstanding while proportionally increasing per-share price
  • Nasdaq Capital Market trading continues under ticker SKIN, with new CUSIP 88331L306
  • Fractional shares paid in cash, creating potential small cash settlements for affected holders
  • Equity awards, plan share limits, purchase rights and exercise prices adjusted under applicable plan terms
  • 7.95% Convertible Senior Secured Notes due 2028 conversion rate adjusted proportionately

Item 7.01 · Regulation FD Disclosure

  • Reverse stock split effective October 14, 2026 at 12:00 a.m. Eastern Time
  • Shareholders should expect adjusted share counts and per-share metrics following the split
  • Exhibit 99.1 contains the company’s detailed announcement and implementation information

Item EX-99.1 · Exhibit EX-99.1

  • 1-for-20 reverse split effective October 14, 2026, with split-adjusted Nasdaq trading under SKIN and new CUSIP 88331L306
  • Shares outstanding expected to decline from approximately 130.3 million to 6.5 million, without changing ownership percentages
  • Primary objective: regain Nasdaq’s $1.00 minimum bid-price compliance and avoid potential delisting
  • Lower share count may reduce trading liquidity, while sustained price recovery and Nasdaq compliance remain uncertain
  • 7.95% Convertible Senior Secured Notes due 2028 conversion rate adjusted proportionately

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Beauty Health Co 8-K filings

Get the next SKIN 8-K as it lands

Follow SKIN for push alerts, or ask the research agent what this filing means.